Metabolic Disorder

Metabolic

8 drugs in development·7 companies·7 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
Alinity® family	ABBOTT LABORATORIES (ABT)

Phase 3(1)

Drug	Company
VK2375	Viking Therapeutics, Inc. (VKTX)

Preclinical(6)

Drug	Company
aln1001	Alaunos Therapeutics, Inc. (TCRT)
aln1003	Alaunos Therapeutics, Inc. (TCRT)
igc-1a	IGC Pharma, Inc. (IGC)
ko-7246	Kura Oncology, Inc. (KURA)
lx9851	LEXICON PHARMACEUTICALS, INC. (LXRX)
undisclosed rare metabolic disorder program	Korro Bio, Inc. (KRRO)

BioSniper tracks 8 drugs in development for Metabolic Disorder across 7 companies.

There are 7 clinical trials targeting Metabolic Disorder tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.